Intended use Sr-89 is among the most effective modern therapeutic agents utilized for palliative treatment of patients with metastatic tumors in the prostate, breast, kidneys, and lungs. Sr-89 is also employed as an alternative method (or as a supplement to external beam therapy) for the management of pain syndrome in bone cancer.
Grade: 1. Non-carrier added radionuclide; 2. GMP product; 3. Tested for sterility and bacterial endotoxins.
Chemical form: 89Strontium solution as a chloride Half-life period: 50.5 days Concentrations, mg/ml: 10.9-22.6 Concentrations, mg/ml: 10.9-22.6 Concentrations of Radioactive Impurities (relative to 89Sr activity), %: 90Sr: ≤2.0×10-4 Other Radionuclides: ≤1.0×10-3 Other γ-emitting Impurities: ≤0.35 Radioactive concentrations, MBq/ml: 33.3-40.7 on production date
Other products
Click to order
Запросить продукт
Total:
Оставьте заявку на заказ товара и наш менеджер свяжется с вами в ближайшее время